The vascular closure device market is supported by the rising volume of catheterization procedures and growing demand for faster patient recovery and same-day discharge protocols. North America ...

Austin, United States, May 22, 2026 (GLOBE NEWSWIRE) -- “SNS Insider reported that global Vascular Closure Devices Market was valued at USD 1.92 billion in 2025 and is projected to reach USD 4.08 ...

CyndRx, LLC, announced FDA approval of its AbsorbaSeal vascular closure device. AbsorbaSeal is designed for acute arterial access s ...

Haemonetics Corporation HAE recently gained CE mark certification for the VASCADE vascular closure and VASCADE MVP venous vascular closure systems. The VASCADE system is intended for ‘small-bore’ ...

The Gore Viabahn Fortegra venous stent is designed for patients with deep venous disease.

Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing ...

The explosion of innovation in valve replacement and repair markets is opening a huge opportunity for percutaneous vessel closure devices. Edward Lifesciences’s FDA nod for the Evoque Transcatheter ...

WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Consultant ...